Russia expects to produce between 1.5 million and 2 million doses per month of its potential COVID-19 vaccine by the year end, gradually ramping up production to 6 million doses a month, the RIA news agency cited industry minister Denis Manturov as saying on Sunday.
Large-scale testing of the vaccine, developed by Moscow's Gamaleya institute, is due to start in Russia next week.
The BIST name and logo are protected under the "Protected Trademark Certificate" and cannot be used, quoted, or altered without permission.All rights to the information disclosed under the BIST name are entirely owned by BIST and cannot be republished. Market data is provided by iDealdata Financial Technologies Inc. BIST stock data is delayed by 15 minutes.